AAP
GOSS icon

Arax Advisory Partners’s Gossamer Bio GOSS Stock Holding History

Arax Advisory Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Buy
+1,353
New +$30.2K ﹤0.01% 4035
2026
Q1 		– Hold
0
– -$93 – 4017
2025
Q4 		– Sell
-136
Closed -$31K – 3838
2025
Q3 		$28.6K Buy
+136
New +$24K ﹤0.01% 2109

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Arax Advisory Partners's GOSS Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Gossamer Bio (GOSS) in Q2 2026: 1,353 shares worth $17.8K. The stake represents ﹤0.01% of the portfolio and ranks #4035 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in GOSS as recently as Q3 2025.

Arax Advisory Partners first reported a position in GOSS in Q3 2025 and has held it in 2 quarters since. The position peaked at $28.6K in Q3 2025. 166 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Arax Advisory Partners held 1,353 shares of Gossamer Bio worth $17.8K as of Q2 2026.
  • Gossamer Bio was a new Arax Advisory Partners position in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4035 holding.
  • Arax Advisory Partners first reported a position in Gossamer Bio in Q3 2025 and has held it in 2 quarters since.
  • Arax Advisory Partners's Gossamer Bio position peaked at $28.6K in Q3 2025.
  • 166 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.